24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension.
about
The efficacy and safety of triple vs dual combination of angiotensin II receptor blocker and calcium channel blocker and diuretic: a systematic review and meta-analysisEffects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZEffect of Olmesartan-Based Therapies on Therapeutic Indicators Obtained Through Out-of-Office Blood PressureRationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.Three in one: safety, efficacy, and patient acceptability of triple fixed-dose combination medicine in the management of hypertension.Essential oil inhalation on blood pressure and salivary cortisol levels in prehypertensive and hypertensive subjects.Current perspectives on combination therapy in the management of hypertension.Evaluation of effectiveness and safety of amlodipine/valsartan/hydrochlorothiazide single-pill combination therapy in hypertensive patients: an observational studyA review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertension.Angiotensin receptor blockers: pharmacology, efficacy, and safety.Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trials.Management of hypertension with fixed-dose triple-combination treatments.Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD.Device-Based Therapy for Drug-Resistant Hypertension: An Update.Triple-combination therapy in the treatment of hypertension: a review of the evidence.Office and ambulatory blood pressure control in hypertensive patients treated with different two-drug and three-drug combinations.Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status.Renal denervation for the treatment of hypertension: Making a new start, getting it right.Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right.Amlodipine as an antiischemic drug is superior to long acting nitrates.
P2860
Q27009509-4240D003-352B-4ADF-9E49-5879E04746CAQ33903371-448C182A-25F2-4D46-80C4-EC8076CA5097Q35610698-058B26F2-7035-42D7-963C-83C5A851E763Q35798623-EDDDFCA9-44D9-4DA4-83A0-ACB3709068BEQ36058755-0FBD52DF-1CAB-432D-9716-A847016E6356Q36173150-293D4C32-8820-4D14-B1C4-9B4C326A7EAEQ36464298-C0B6F74F-C98C-42BC-B3CF-F970196CAFC2Q36975801-C620B39C-8327-4B1C-80A1-F829A1042054Q37077156-7A7C7887-8F60-4045-A7D7-C49ECADDA0BBQ37192911-F89DB1A5-9FE2-483A-B1A6-85E7D3BEA310Q37928133-570CE86A-AF5F-4B7C-A91D-360598537A72Q38011638-455FECF6-DC84-4068-BEC9-DFC96D41883FQ38129014-65189C20-9FBC-4DA7-AAB7-39273FC66EBCQ38145263-1F07FF77-C2FE-4B52-A8F2-B93C2F57A664Q38893138-95AAB5EB-0755-418B-BE90-C0190929A8A0Q39147724-4F5A7889-22B6-47C6-B309-3EC7C9DED954Q39782957-5715D9D1-678C-4FA4-9AEE-2C717B43CC89Q48131950-609A9D41-2D96-4F04-A50D-0AE5CC23F381Q48453071-877895B3-2A43-4B06-AF2F-743A921ADB90Q53405590-AFC9FC9E-7838-401E-BEC1-2C94364C6977Q53777785-8C309FFB-981E-4663-8C14-632DA403F8ED
P2860
24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
24-Hour ambulatory blood press ...... derate to severe hypertension.
@ast
24-Hour ambulatory blood press ...... derate to severe hypertension.
@en
type
label
24-Hour ambulatory blood press ...... derate to severe hypertension.
@ast
24-Hour ambulatory blood press ...... derate to severe hypertension.
@en
prefLabel
24-Hour ambulatory blood press ...... derate to severe hypertension.
@ast
24-Hour ambulatory blood press ...... derate to severe hypertension.
@en
P2093
P2860
P356
P1476
24-Hour ambulatory blood press ...... derate to severe hypertension.
@en
P2093
D A Calhoun
N Crikelair
R D Glazer
Y Lacourcière
P2860
P2888
P304
P356
10.1038/JHH.2010.115
P577
2011-01-20T00:00:00Z